Related Experiment Video
Updated: Jun 1, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
EGF stimulates cyclooxygenase-2 expression through the STAT5 signaling pathway in human lung adenocarcinoma A549
Shouqiang Cao1, Yubo Yan, Xiangyu Zhang
1Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, PR China.
Abstract:
The epidermal growth factor receptor (EGFR) can be activated by several growth factors within the tumor microenvironment, and it can activate several signaling pathways. For tumor development, these EGFR-related signaling pathways may converge on several common nuclear transcription factors, one such transcription factor being STAT5. STAT5 plays an important role in the oncogenic signal transduction pathway in non-small cell lung cancer. In this study, we examined whether the epidermal growth factor (EGF) can stimulate cyclooxygenase-2 (COX-2) expression in human lung adeno-carcinoma A549 cells transfected with or without STAT5 siRNA or dominant-negative (DN)-STAT5, and identified the pathways involved in this response. We found that STAT5 siRNA significantly reduced EGF-induced COX-2 expression, and STAT5 phosphorylation. STAT5 phosphorylation predominantly mediates EGF-induced COX-2 promoter activity. STAT5 siRNA was found to inhibit COX-2 expression in resting A549 cells despite the absence of detectable activated phosphorylated STAT5. Using an adenoviral system, we expressed DN-STAT5 in human lung adenocarcinoma A549 cells in order to broaden the investigation and to determine the role of STAT5 in EGF-mediated COX-2 gene expression. The overexpression of DN-STAT5 significantly inhibited EGF-induced COX-2 expression, and we found that EGF induced the tyrosine phosphorylation of STAT5 and up- regulated COX-2 expression. DN-STAT5 also blocked COX-2 promoter activity. Our results demonstrate that EGF stimulates COX-2 expression in human lung adenocarcinoma A549 cells via the activation of the STAT5 pathway and that COX-2 expression may be independent of phosphorylated STAT5 in A549 cells in vitro.
Insights
Epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) in lung cancer cells by activating STAT5. This study reveals STAT5
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Epidermal growth factor receptor (EGFR) signaling pathways are crucial for tumor development.
- Signal transducer and activator of transcription 5 (STAT5) is a key transcription factor in oncogenic signaling pathways, particularly in non-small cell lung cancer.
- EGFR activation can lead to the activation of downstream pathways converging on transcription factors like STAT5.
Purpose of the Study:
- To investigate whether epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) expression in human lung adenocarcinoma A549 cells.
- To identify the specific signaling pathways involved in EGF-mediated COX-2 expression, with a focus on STAT5.
- To elucidate the role of STAT5 phosphorylation and activity in regulating COX-2 expression.
Main Methods:
- Utilized STAT5 small interfering RNA (siRNA) to reduce STAT5 expression in A549 cells.
- Employed dominant-negative (DN)-STAT5 expression via an adenoviral system to inhibit STAT5 activity.
- Assessed EGF-induced COX-2 expression, STAT5 phosphorylation, and COX-2 promoter activity.
- Investigated COX-2 expression in resting A549 cells to understand basal regulation.
Main Results:
- STAT5 siRNA significantly reduced EGF-induced COX-2 expression and STAT5 phosphorylation.
- STAT5 phosphorylation was found to be the primary mediator of EGF-induced COX-2 promoter activity.
- Overexpression of DN-STAT5 significantly inhibited EGF-induced COX-2 expression and blocked COX-2 promoter activity.
- EGF stimulation led to STAT5 tyrosine phosphorylation and subsequent COX-2 upregulation.
- STAT5 siRNA inhibited COX-2 expression even in resting cells lacking detectable phosphorylated STAT5.
Conclusions:
- Epidermal growth factor (EGF) stimulates cyclooxygenase-2 (COX-2) expression in human lung adenocarcinoma A549 cells through the activation of the STAT5 pathway.
- STAT5 plays a critical role in mediating EGF-induced COX-2 expression and promoter activity.
- The regulation of COX-2 expression by EGF in A549 cells may involve mechanisms independent of phosphorylated STAT5 under certain conditions (in vitro).
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
GPCRs Regulate Adenylyl Cylase Activity
Two...
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

